Related Experiment Video
Updated: May 11, 2026
07:22
A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
Published on: March 14, 2025
Topical steroids for chronic wounds displaying abnormal inflammation.
D C Bosanquet1, A Rangaraj, A J Richards
1Cardiff University School of Medicine, UK. davebosanquet@hotmail.com
Annals of the Royal College of Surgeons of England
|May 17, 2013
Summary
Topical steroid, antibiotic, and antifungal preparations can accelerate healing in chronic wounds with excessive inflammation. This treatment also reduced pain and exudate, improving patient outcomes in wound management.
Area of Science:
- Dermatology
- Wound Healing Research
- Pharmacology
Background:
- Chronic wounds often exhibit prolonged and harmful inflammatory responses, hindering natural healing processes.
- Excessive inflammation in non-healing wounds necessitates targeted therapeutic interventions.
Purpose of the Study:
- To evaluate the efficacy of a combined topical steroid, antibiotic, and antifungal preparation in managing chronic wounds with significant inflammation.
- To assess the impact of this treatment on wound healing rates and symptom burden.
Main Methods:
- Retrospective review of patients treated with a topical steroid (clobetasone butyrate 0.05%), antibiotic, and antifungal at a specialized wound care center.
- Analysis of healing rates and symptom changes (pain, odor, exudate) before and during treatment over a ten-year period.
Main Results:
- Faster healing rates were observed in 24 out of 34 chronic ulcers treated with the combined preparation (p=0.0006).
- The treatment effectively reduced pain and exudate levels, although odor remained unaffected.
- A small number of ulcers showed no change or slower healing rates during the intervention.
Conclusions:
- Topical corticosteroids, when combined with antimicrobials, may expedite healing in chronic wounds by modulating excessive inflammation.
- Further research is needed to clarify the specific role of topical steroids alone in chronic wound management.
Related Concept Videos
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
01:12Chronic Inflammation: Introduction
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
01:24Inflammatory Response II: Inflammatory Exudate and Tissue Repair
The immune system's inflammatory response destroys the invading pathogen, permitting the tissue to heal. The changes during the cellular and vascular stages allow exudate formation at the site of inflammation. The inflammatory exudate released from the wound has high protein content and a specific gravity above 1.020.
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the exudate's...
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the exudate's...
01:19Clinical Applications of Epidermal Stem Cells
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...